SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-148266
Filing Date
2023-05-18
Accepted
2023-05-18 17:02:06
Documents
16
Period of Report
2023-05-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d480273d8k.htm   iXBRL 8-K 26738
2 EX-1.1 d480273dex11.htm EX-1.1 195931
3 EX-5.1 d480273dex51.htm EX-5.1 14308
7 GRAPHIC g480273lw1.jpg GRAPHIC 7849
8 GRAPHIC g480273lw2.jpg GRAPHIC 5669
  Complete submission text file 0001193125-23-148266.txt   435180

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA chrs-20230516.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20230516_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20230516_pre.xml EX-101.PRE 11262
10 EXTRACTED XBRL INSTANCE DOCUMENT d480273d8k_htm.xml XML 3362
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 23936943
SIC: 2836 Biological Products, (No Diagnostic Substances)